AKTX - Akari Therapeutics Plc
0.257
0.006 2.257%
Share volume: 756,181
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$0.25
0.01
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-19-2024 | 11-19-2024 | 05-14-2025 | 08-13-2025 | 11-13-2025 | |
| Cash flow financing | 1.514 M | 7.763 M | -443.000 K | 2.133 M | 3.381 M | 1.897 M | |
| Other financing cash flows | 0.000 | 0.000 | 29.000 K | 1.090 M | 0.000 | 0.000 | |
| Cash flow | -2.530 M | 0.000 | 0.000 | -17.000 K | 0.000 | 0.000 | |
| Net income | -5.566 M | -7.558 M | -2.895 M | -3.705 M | -1.895 M | -6.400 M | |
| Depreciation | 13.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -2.535 M | 2.867 M | -1.931 M | -17.000 K | 129.000 K | -227.000 K |